08
Nov
Montpellier – France – November 7th, 2024 – Cilcare, a clinical-stage biotechnology company specializing in the development of innovative therapies for inner ear disorders, is pleased to announce the appointment of Dr. Mélanie Berta as Project Manager, Drug Development. With a robust background in Pharmaceutical Program Management and Cross-functional Team Leadership, Dr. Berta brings a wealth of expertise to Cilcare’s flagship program, CIL001. In her new role, she will oversee CIL001’s progression to clinical development, ensuring its advancement toward key...